SHASHIKANT CHAUBEY
2 years 11 months ago
The Government of India has sanctioned Rs.900 crores for the Phase I of the Mission COVID Suraksha, for a period of 12 months
This mission will accelerate the development of approximately 5-6 vaccines for coronavirus. However, a total of 10 vaccine candidates have been supported by DBT till now
Complete focus on the preclinical and clinical development of the vaccine is to be taken care of, for quick release and to restrict any further spread of the Novel coronavirus in the country
With an end-to-end focus from preclinical development through clinical development and manufacturing and regulatory facilitation for deployment, would consolidate all available and funded resources towards an accelerated product development
The grant for Research and Development (R&D) of the Indian COVID-19 vaccine will be provided by the Department of Biotechnology (DBT)
Like
(7)
Dislike
(0)
Reply
Report Spam